Projects per year
Fingerprint Dive into the research topics where Charles Lopez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 5 Similar Profiles
Apoptosis
Medicine & Life Sciences
Colorectal Neoplasms
Medicine & Life Sciences
irinotecan
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
gemcitabine
Medicine & Life Sciences
Pancreatic Neoplasms
Medicine & Life Sciences
Proteins
Medicine & Life Sciences
Drug Therapy
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 2000 2010
- 2 Finished
Apoptosis
Proteins
Neoplasms
Carrier Proteins
Proteins
DNA Damage
Neoplasms
Up-Regulation
Research Output 1990 2019
11
Citations
(Scopus)
Activation of PP2A and inhibition of mTOR synergistically reduce MYC signaling and decrease tumor growth in pancreatic ductal adenocarcinoma
Allen-Petersen, B. L., Risom, T., Feng, Z., Wang, Z., Jenny, Z. P., Thoma, M. C., Pelz, K. R., Morton, J. P., Sansom, O. J., Lopez, C., Sheppard, B., Christensen, D. J., Ohlmeyer, M., Narla, G. & Sears, R., Jan 1 2019, In : Cancer Research. 79, 1, p. 209-219 11 p.Research output: Contribution to journal › Article
Protein Phosphatase 2
Adenocarcinoma
Phosphoric Monoester Hydrolases
Phosphotransferases
Growth
Alternative splicing of the tumor suppressor ASPP2 results in a stress-inducible, oncogenic isoform prevalent in acute leukemia
Schittenhelm, M. M., Walter, B., Tsintari, V., Federmann, B., Bajrami Saipi, M., Akmut, F., Illing, B., Mau-Holzmann, U., Fend, F., Lopez, C. & Kampa-Schittenhelm, K. M., Apr 1 2019, In : EBioMedicine. 42, p. 340-351 12 p.Research output: Contribution to journal › Article
Open Access
Tumor Suppressor Protein p53
Alternative Splicing
Tumors
Protein Isoforms
Leukemia
A Phase II Study Alternating Erlotinib With Second-line mFOLFOX6 or FOLFIRI for Metastatic Colorectal Cancer
Kearney, M. R., Chen, E. Y., Vaccaro, G., Strother, J., Burt, A., Todd, K., Donovan, J., Kampa-Schittenhelm, K. M. & Lopez, C., Jan 1 2019, In : Anticancer Research. 39, 1, p. 245-252 8 p.Research output: Contribution to journal › Article
irinotecan
Colorectal Neoplasms
oxaliplatin
Neutropenia
Combination Drug Therapy
Evolving Treatment Options and Future Directions for Locally Advanced Rectal Cancer
Chen, E. Y., Kardosh, A., Nabavizadeh, N. & Lopez, C., Jan 1 2019, In : Clinical Colorectal Cancer.Research output: Contribution to journal › Review article
Rectal Neoplasms
Neoadjuvant Therapy
Radiation-Sensitizing Agents
Neoplasm Metastasis
Drug Therapy
5
Citations
(Scopus)
A Phase II Study of Celecoxib with Irinotecan, 5-Fluorouracil, and Leucovorin in Patients with Previously Untreated Advanced or Metastatic Colorectal Cancer
Chen, E. Y., Blanke, C., Haller, D. G., Benson, A. B., Dragovich, T., Lenz, H. J., Robles, C., Li, H., Mori, M. T., Mattek, N., Sanborn, R. E. & Lopez, C., Dec 1 2018, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 12, p. 1193-1198 6 p.Research output: Contribution to journal › Article
irinotecan
Celecoxib
Leucovorin
Fluorouracil
Colorectal Neoplasms